Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
From July 01 RNS
The results of the project found that SDC-1801 reduced the levels of cytokines associated with Acute Respiratory Distress Syndrome (ARDS) in human lung cells infected with SARS-CoV-2 and demonstrated a profile that was superior to the anti-inflammatory steroid dexamethasone and similar to baricitinib, a JAK1/JAK2 inhibitor. (But no tox issues)
There must have been an approach by now from one of the major players - maybe it’s well underway.
GLTALTH
COYB
https://masterinvestor.co.uk/equities/stocks-in-focus-sareum-holdings/
Thanks Paul
I do like a share with a good upside and of course that is also most usually shrouded in risk. I only came across MGC because of my investment in Sareum Holdings and subsequently the link with Stephen Parker. Not ramping but with a look- I’ve had to wait over 10 years!
I live in Portugal and the cannabis production here is huge so had started to delve into various avenues of investment but those that I’ve followed so far like Tilray and Canopy Growth have yet to look like supplying the buds of success in looking for. No investment yet but keen to hear a seasoned overview here if you would care to.
Thanks in advance
Tjb
I’m not invested here yet but just doing some research and was wondering if Medicanil were paid in shares is that still pending?
There seems to be plenty of outstanding options and I worry about dilution
Thanks ATB
RMM,
Wow what fantastic research and so well put together.
Totally underpins the reasons to be invested here and the reasons to only sell in tranches so I can take my original investment around 20p but still have a big investment that would be very life changing.
What a company to be involved in!!
??????????????Bom fim do semana ????
I remember you from the early days and certainly remember Range, Ascent and another I’m still in called Verona Pharma. All hounds of varying degrees.
I’m sitting on 1m shares so have a selling strategy that will give me a very decent windfall in different tranches and still leave a decent chunk for a longer game as who knows where this could be in two years time £3/4/5 a share and I wouldn’t want to miss out.
Bom fim do semana amigos
Thanks Stoney
Your post really sums it up. It reiterated to us LTH why we invested so long ago, it’s always been about the science!!
The science is so strong and the IP of that science is so well protected -these things take time but the building blocks are in place.
Happy investors are looking for something that is hugely innovative or a medical blockbuster or turning over a stone that uncovers a long lost seam of pay dirt. We’ve probably got all of that rolled into one and it’s ours - nobody else has what we have.
I’m very excited at the prospects of what is going to transpire over the following days, weeks and months.
GL all whether you’re in for a quick buck for for the end game !